Smith & Nephew plc (LON:SN) had its price target increased by J P Morgan Chase & Co from GBX 1,280 ($16.62) to GBX 1,361 ($17.67) in a research note issued to investors on Monday, July 31st. They currently have a neutral rating on the stock.
A number of other equities analysts have also recently weighed in on SN. Deutsche Bank AG reissued a hold rating and set a GBX 1,200 ($15.58) price target on shares of Smith & Nephew plc in a research report on Friday, July 28th. Goldman Sachs Group, Inc. (The) reissued a neutral rating and set a GBX 1,270 ($16.49) price target on shares of Smith & Nephew plc in a research report on Friday, May 5th. Credit Suisse Group reissued a neutral rating and set a GBX 1,200 ($15.58) price target on shares of Smith & Nephew plc in a research report on Thursday, July 20th. Jefferies Group LLC lifted their price target on shares of Smith & Nephew plc from GBX 1,350 ($17.53) to GBX 1,515 ($19.67) and gave the stock a buy rating in a research report on Friday, July 28th. Finally, HSBC Holdings plc reissued a hold rating and set a GBX 1,320 ($17.14) price target on shares of Smith & Nephew plc in a research report on Monday, July 10th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. The company has a consensus rating of Hold and an average price target of GBX 1,289.25 ($16.74).
Shares of Smith & Nephew plc (LON SN) opened at 1361.00 on Monday. The firm’s 50-day moving average is GBX 1,327.08 and its 200 day moving average is GBX 1,284.92. The firm’s market capitalization is GBX 11.92 billion. Smith & Nephew plc has a 52 week low of GBX 1,064.91 and a 52 week high of GBX 1,389.33.
COPYRIGHT VIOLATION NOTICE: “Smith & Nephew plc (SN) Given New GBX 1,361 Price Target at J P Morgan Chase & Co” was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://stocknewstimes.com/2017/08/18/smith-nephew-plc-sn-price-target-raised-to-gbx-1361-updated-updated.html.
The business also recently disclosed a dividend, which will be paid on Wednesday, November 1st. Investors of record on Thursday, October 5th will be given a $0.12 dividend. The ex-dividend date of this dividend is Thursday, October 5th. This represents a yield of 0.72%.
In other Smith & Nephew plc news, insider Virginia Bottomley purchased 223 shares of the stock in a transaction on Wednesday, August 16th. The shares were purchased at an average cost of GBX 1,380 ($17.92) per share, for a total transaction of £3,077.40 ($3,995.07).
Smith & Nephew plc Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.
